Green Valley Sugar Drug Production Base in Shanghai International Medical Park officially started laying the foundation.

Guide: Green Valley Sugar Drug Production Base in Shanghai Foundation Project Investment Total Rmb100 million Green Valley Sugar Drug Production Base in Shanghai International Medical Park officially started laying the foundationAfter Shanghai Qingpu base and Liaoning Benxi base, this will be Green Valley Pharmaceutical's third standard production base will become the first domestic sugar drug export global production baseThe total investment of the project is expected to be completed by the end of the year acceptance and put into operation area will reach 10,000 square meters by the Eighth Engineering Bureau of China Construction for the total package constructionGreen Valley sugar drug production base in accordance with China, the United States, the European Union tripartite production requirements of the construction is committed to ensure the quality of production and international standardsGreen Valley Sugar Drug Production Base Effect Map as a chinese innovative pharmaceutical company in the field of chronic complex diseases to create a new treatment strategy, the first by China's original, and fully independent intellectual property rights of the first innovative sugar drug Phase 9 ® was approved for the treatment of mild to moderate Alzheimer's disease to improve patients' cognitive function to fill the global market-free gap in this fieldWhen the production base of Green Valley Sugar Drug is completed and put into operation, it will greatly improve the production capacity of the nine-phase first ® and series of sugar drugs to meet the needs of more patientsWith the promotion of Phase 9 phase 1 clinical trial satios ® phase 9, the phase 1 ® is expected to become China's first globally available new drug for Alzheimer's diseaseHealth China Action has been a national strategic focus of which the Elderly Health Promotion Initiative clearly put forward to the year and the year to achieve the age of the age of the age of the age of the inability rate has decreased the rate of dementia prevalence decline in the elderly populationThe birth of Green Valley Pharmaceuticals' phase 9 ®, as a positive response to China's innovative pharmaceutical companies, and the production of future production bases will undoubtedly help to achieve the ambitious goal of "Healthy China"